SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016709
Filing Date
2017-08-09
Accepted
2017-08-08 21:36:35
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-10q_20170630.htm 10-Q 1467703
2 EX-31.1 nktr-ex311_6.htm EX-31.1 16068
3 EX-31.2 nktr-ex312_8.htm EX-31.2 16080
4 EX-32.1 nktr-ex321_7.htm EX-32.1 7772
  Complete submission text file 0001564590-17-016709.txt   4578242

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20170630.xml EX-101.INS 724646
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20170630.xsd EX-101.SCH 48964
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20170630_cal.xml EX-101.CAL 45042
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20170630_def.xml EX-101.DEF 124715
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20170630_lab.xml EX-101.LAB 330726
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20170630_pre.xml EX-101.PRE 229129
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 171016260
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences